Inactivation of Chk2 and Mus81 leads to impaired lymphocytes development, reduced genomic instability, and suppression of cancer

16Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

Abstract

Chk2 is an effector kinase important for the activation of cell cycle checkpoints, p53, and apoptosis in response to DNA damage. Mus81 is required for the restart of stalled replication forks and for genomic integrity. Mus81Δex3-4/Δex3-4 mice have increased cancer susceptibility that is exacerbated by p53 inactivation. In this study, we demonstrate that Chk2 inactivation impairs the development of Mus81Δex3-4/Δex3-4 lymphoid cells in a cell-autonomous manner. Importantly, in contrast to its predicted tumor suppressor function, loss of Chk2 promotes mitotic catastrophe and cell death, and it results in suppressed oncogenic transformation and tumor development in Mus81Δex3-4/Δex3-4 background. Thus, our data indicate that an important role for Chk2 is maintaining lymphocyte development and that dual inactivation of Chk2 and Mus81 remarkably inhibits cancer. © 2011 El Ghamrasni et al.

Cite

CITATION STYLE

APA

El Ghamrasni, S., Pamidi, A., Halaby, M. J., Bohgaki, M., Cardoso, R., Li, L., … Hakem, R. (2011). Inactivation of Chk2 and Mus81 leads to impaired lymphocytes development, reduced genomic instability, and suppression of cancer. PLoS Genetics, 7(5). https://doi.org/10.1371/journal.pgen.1001385

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free